IngentaConnect Endoscopic Ultrasound Fine Needle Aspirate DNA Analysis to Differ...

Authors: Khalid, Asif¹; Nodit, Laurentia²; Zahid, Maliha³; Bauer, Kathy³; Brody, Debra³; Finkelstein, Sydney D.⁴; McGrath, Kevin M.³

Source: The American Journal of Gastroenterology, Volume 101, Number 11, November 2006 , pp. 2493-2500(8)

Publisher: Blackwell Publishing

Abstract:

OBJECTIVES: Accurate diagnosis of malignant and benign pancreatic masses can be challenging, potentially delaying treatment for cancer and subjecting patients with benign disease to unnecessary surgery. Endoscopic ultrasound fine needle aspirate (EUS-FNA) of pancreatic masses remains inconclusive in a subset of patients. The role of EUS-FNA molecular analysis in this context is studied.

METHODS: Patients with benign pancreatic masses (6 cases, 4 autoimmune pancreatitis, 2 focal chronic pancreatitis) and malignant pancreatic masses ( 15) with inconclusive cytology (5 cases) and positive cytology (10 controls) were selected. All cases had definitive pathology. Representative cells were microdissected from each EUS-FNA sample and subjected to PCR for analysis of 16 microsatellite allele loss markers situated at 1p, 3p, 5q, 9p, 9q, 10q, 17p, 17q, 21q, and 22q. Loss of heterozygosity analysis used fluorescent capillary electrophoresis for quantitative determination of allelic imbalance. k-ras-2 point mutation analysis was also performed. Mean fractional mutation rate (FMR) was calculated and compared for each group.

RESULTS: All malignant cases carried multiple mutations (FMR 0.50), regardless of positive cytology (FMR 0.52) or suspicious cytology (FMR 0.47) (p= NS). Five of the 6 benign cases carried no mutations whereas 1 case of autoimmune pancreatitis and coexisting PanIN lesions exhibited a k-ras mutation (FMR 0.01). The mean FMR for the malignant and benign samples was significantly different (p < 0.0001).

CONCLUSIONS: Broad panel microsatellite loss and k-ras point mutation analysis can be reliably performed on EUS-FNA samples from pancreatic masses and improves the diagnostic accuracy. Furthermore, it accurately differentiates between malignant and benign pancreatic masses.

(Am J Gastroenterol 2006;101:2493-2500)

Document Type: Research article

DOI: 10.1111/j.1572-0241.2006.00740.x

Affiliations: 1: Department of Medicine, The University of Pittsburgh and VA Pittsburgh Health Care, Pittsburgh, Pennsylvania 2: Department of Pathology 3: Department of Medicine, The University of Pittsburgh, Pittsburgh, Pennsylvania 4: RedPath Integrated Pathology, Inc, Pittsburgh, Pennsylvania

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.39 plus tax Refund Policy

Endoscopic Ultrasound Fine Needle Aspirate DNA Analysis to Differentiate Malignant and Benign Pancreatic Masses